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1. Introduction 
1.1 Formaldehyde (FA) in the human environment 
FA (H2CO), the simplest aldehyde (Kilburn, 1994), existed in the pre-biological atmosphere 
of the primordial earth (Canuto et al., 1983) and is also present in the outer galaxies (Blair et 
al., 2008). FA is believed to have been the first organic molecule, being derived from 
photochemical reactions between simple gas elements in the primeval earth’s atmosphere 
(Reaction 1) (Pinto et al., 1980; Canuto et al., 1983). 
 CO2 + 2H2 → H2CO + H2O (h)   (1) 
FA is also a basic biological building block, and participates in the synthesis of amino acids 
such as glycine and alanine in aqueous medium (Miller, 1953; Sokolskaya, 1976; 
Sakurai&Yanagawa, 1984). It is involved in the generation of carbohydrates via the formose 
cycle in bacteria (Kalapos, 1999). FA is believed to form complex organic molecules (Canuto 
et al., 1983) and play a key role in the process of evolution (Kalapos, 1999). 
As reported by the U.S. Environmental Protection Agency (June 18, 2010), FA is present in 
products such as abrasive materials, plywood adhesives, insecticides, insulation and 
embalming fluids. Anthropogenic production of FA is mainly from power plants, petroleum 
refineries, coking operations, incineration, motor vehicle exhaust, and tobacco smoke (He et 
al., 2010). This simplest aldehyde has become one of the highest risk factors in the pollution 
of the human environment. 
1.2 Toxicity of exogenous formaldehyde and cognitive impairments 
Due to its high reactivity, FA leads to the formation of stable methylene bridges between 
nucleic acids and the amines of proteins (Conaway et al., 1996), resulting in crosslinking 
between nucleic acids and/or proteins and their subsequent polymerization (Kast et al., 
2008). Both the amino-terminals of proteins and residues containing ε-amino and thiol 
groups, such as lysine, arginine, histidine, cysteine, tyrosine and tryptophan, are modifiable 
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targets of FA, and form methylol groups or Schiff-bases after modification (Metz et al., 
2004). A number of reports have indicated that FA usually acts as a chemical crosslinker for 
biomacromolecules in cells. Exposure to FA at a concentration of 0.21 mM for 6 h reduces 
the growth rate of human bronchial epithelial cells to 50% that of controls due to FA 
depression of RNA synthesis and the formation of both DNA single-strand breaks and 
DNA-protein crosslinks (DPCs) (Saladino et al., 1985). When cultured with FA at 
concentrations of 0.1-0.3 mM, human lung A549 cells, primary human nasal epithelial cells 
and DT40 cells undergo the process of DPC formation (Nakamura et al., 2007; Speit et al., 
2008). Treatment of rat aorta endothelial cells with FA at 0.01-2.00 mM promotes the 
formation of DPC, a potential risk factor in atherosclerosis (Yu&Deng, 1998; Zhang et al., 
2006). FA has also been shown to induce chromosomal aberrations (CAs) and sister 
chromatid exchanges (SCEs) in cultured cells (Conaway et al., 1996). It is worth noting that 
FA has biphasic effects on cell lines depending on its concentration: enhancing apoptosis, 
necrosis and even causing cell death at high concentrations (＞1 mM), while promoting cell 
proliferation at low dose (0.1 mM) (Tyihak et al., 2001).  
Excess exposure to exogenous FA can induce carcinogenesis and cardiovascular 
dysfunction, possibly due to the formation of DPC (Shaham et al., 2003). Inhalation of FA 
vapor at concentration of up to 0.50 mM can cause rhinitis, epithelial dysplasia, squamous 
metaplasia, and even squamous cell carcinomas in rodents (Swenberg et al., 1980). Similar 
results have also been observed in a study on monkeys exposed to FA at 0.20 mM (Conaway 
et al., 1996). Tumor generation has been observed in humans when excess FA has been 
inhaled over a long period (Soffritti et al., 2002). In addition, oral administration of FA in 
drinking water at concentrations of 33.3 mM and 166.5 mM can cause hyperplasia, 
hyperkeratosis, erosion and/or ulcers in the alimentary system of rats (Conaway et al., 
1996). Exposure to FA vapor also induces myocardical ischemia (Rety&Marin, 1957), while 
rats infused with 0.12 mM FA suffer cardiovascular attacks (Strubelt et al., 1990).  
Studies on the relationship between exogenous FA and the immune system have indicated 
that exposure to FA promotes the response of cultured mast cells (Fujimaki et al., 1992), 
activates the immune system, and increases related antibodies in human sera (Patterson et 
al., 1986; Thrasher et al., 1990).  
An overload of exogenous FA induces damage to the nervous system including changes in 
neurofilament proteins and demyelination (Perna et al., 2001). When exposed to FA, rats 
perform poorly at finding food in a maze, compared with controls (Pitten et al., 2000) and 
are also deficient in locomotor and explorative behavior (Malek et al., 2003). Hsp70 is 
upregulated in neonatal rats which have inhaled 0.40 mM FA for 30 days, leading to 
damage to the hippocampus, such as the loss of neurons and granule cells, and reduction in 
the volume of the dentate gyrus (DG) and cornu ammonis (CA) (Sarsilmaz et al., 2003; 
Petushok et al., 2005; Aslan et al., 2006; Sarsilmaz et al., 2007). Inhalation of FA at a 
concentration of 13.3 ǍM alters the expression of mouse genes, such as N-methyl-D-
aspartate (NMDA) receptor subunits (NR2A and NR2B), cyclic AMP responsive element-
binding protein (CREB)-1, CREB-2, FosB/ΔFosB, dopamine receptor subtypes (D1 and D2) 
and transient receptor potential vanilloid receptor (TRPV1), affecting synaptic plasticity 
(Ahmed et al., 2007; Lu et al., 2008). Epidemiological studies on the exposure of pathologists, 
embalmers, and chemical workers, have shown that increased hours of exposure to FA per 
day are associated with reduced performance in memory, equilibrium, and dexterity, and 
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even result in damage to the central nervous system (Kilburn et al., 1987; Perna et al., 2001; 
Yu et al., 2007) and headache, eye irritation and asthma-like symptoms of wheezing and 
bronchoconstriction (Conaway et al., 1996). 
1.3 Endogenous formaldehyde 
1.3.1 Source of endogenous formaldehyde 
FA is present in living organisms in three states, that is, the free-state, or reversibly or 
irreversibly bound to macromolecules (Zhiqian Tong, 2008). FA is involved in one-carbon 
metabolism and plays a role in physiological processes (Abeles R.H., 1992). Increased levels 
of endogenous FA are believed to be a potential risk factor for health and an indicator of 
either pathological processes, malnutrition or environmental contamination (Kalasz, 2003).  
There are several sources of endogenous FA in living organisms, arising from enzymatic or 
nonenzymatic reactions (Zhiqian Tong, 2008). In plants, FA is produced as a byproduct of 
photosynthesis and is present at a level of 0.5-1.0 mM. After its generation, the aldehyde 
moiety immediately combines with L-arginine to form N(G)-trihydroxymethyl-L-arginine 
(TriHMA) through a series of enyzmic reactions (Trezl et al., 1998).  
In animals, oxidative deamination is considered to be the major source of endogenous FA 
(Yu et al., 2003a). One important enzyme involved in FA generation by deamination is 
semicarbazide-sensitive amine oxidase (SSAO). SSAO, a copper-containing enzyme, is 
located primarily in cardiovascular smooth muscle, cartilage and other organs including the 
lung, liver, duodenum, kidney, and adrenal gland, and is circulated in the blood (Morrison 
et al., 1996; Yu et al., 1997; Mahy et al., 2001). The main substrates of SSAO are aromatic and 
aliphatic amines, which are deaminated into ammonia, hydrogen peroxide and FA as final 
products (Mahy et al., 2001; Conklin et al., 2004). In addition, monoamine oxidase (MAO) A 
and B, enzymes which have a similar function of that of SSAO, also generate FA (Ramonet 
et al., 2003). Adrenaline, whose excretion is enhanced by stress, is deaminated by 
monoamine oxidase (MAO) A and forms methylamine as a product. This product can be 
further deaminated by SSAO, yielding FA in vivo (Yu et al., 1997). In the rat liver 
microsome, N-nitrosodimethylamine can be metabolized into FA via oxidative deamination 
(Keefer et al., 1990). 
FA is also generated in the demethylation step of methionine-homocysteine cycles. For 
example, demethylation of S-adenosyl-L-methionine, a methyl donor in enzymatic 
transmethylation reactions, generates FA (Kalasz, 2003). In addition, Generation of FA can also 
be achieved via demethylation of other substrates. For example, liver mitochondria produce 
FA by the oxidation of sarcosine methyl carbons (Abeles&Mackenzie, 1956). In normal and 
leukemic human leukocytes, N5-methyltetrahydrofolate undergoes an oxidative reaction 
catalyzed by a reductase to form N5,N10-methylenetetrahydrofolate which then spontaneously 
releases FA. Moreover, production of FA is higher in the lymphocytes of chronic lymphocytic 
leukemia patients than in those of healthy individuals (Thorndike&Beck, 1977).  
Histone demethylation is another way of generating FA in vivo (Kalasz, 2003; Ehrlich, 2009). 
Histone demethylases catalyze the removal of histone methyl groups at lysine or arginine 
residues, generating FA as a byproduct (Fang&Tian, 2007). There are two kinds of histone 
demethylases, namely lysine specific demethylase 1 (LSD 1) and Jumonji C (JmjC) domain 
family proteins (Fang&Tian, 2007). LSD1, a nuclear homolog of amine oxidases, functions as 
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a histone demethylase and transcriptional co-repressor, catalyzing the demethylation of 
histone H3 at lysine 4 and the generation of FA (Shi et al., 2004). JHDM1 (JmjC domain-
containing histone demethylase 1), an enzyme which plays a role in the demethylation of 
histone H3 at lysine 36, also releases FA as a product (Zhang et al., 2006).  
Demethylation of DNA and RNA is also believed to involve FA generation. Fat mass and 
obesity associated enzyme (FTO), a Fe(II)-and-2-oxoglutarate-dependent oxygenase, is able 
to demethylate 3-methylthymine in single-stranded DNA, leading to the formation of FA 
(Gerken et al., 2007). In addition, human ABH2 and ABH3, homologues of E. coli AlkB, are 
non-Fe(II)-mediated oxidative demethylases. They are involved in catalysis, releasing the 
methyl carbon of DNA and RNA as FA (He et al., 2009).  
Microsomal cytochrome P-450 dependent oxidation of xenobiotics such as drugs, is another 
demethylation reaction which results in the production of endogenous FA. In addition, 
endogenous FA can also come from food, such as milk, ham, sausage, potato, grape and 
cauliflower (Trezl et al., 1997). 
1.3.2 Analysis of endogenous formaldehyde 
A variety of methods have been established for the analysis of endogenous FA. According 
with the universal principle, measurements by different methods result in different values 
for the concentration of endogenous FA. Dimedone-14C, a reagent for radiometric analysis, 
can be used to estimate the FA concentration in human blood and urine. Using this method, 
FA levels in blood and urine have been shown to vary between 0.01-0.02 mM and 0.08-0.13 
mM, respectively (Szarvas et al., 1986). Gas chromatography (GC) has been used to compare 
the concentration of FA in the expired air of tumor-bearing mice (1.43-2.98 ǍM) and control 
mice (0.77-1.01 ǍM) (Shibamoto et al., 1997). The concentration of FA in urine from healthy 
individuals ranges from 1.89-4.81 ǍM, as determined by gas chromatography (Takigawa et 
al., 2007). The level of FA in the rat brain is reported to be 0.33-30.0 ǍM, as determined by 
GC-MS (P. Maboudou, 2002). Using selected ion flow tube mass spectrometry (SIFT-MS), 
the mean values of urine FA concentrations in patients with prostate cancer and bladder 
cancer was shown to be 0.83 ǍM and 2.83 ǍM, respectively, compared with 0.37 ǍM in 
healthy controls (Smith et al., 1999). In another study, preconcentration of the body fluid 
samples rendered FA more detectable by SIFT-MS. FA concentrations in Hela S3 cervical 
cancer, K562 leukemia and MCF-7 breast cancer cell lines range from 1.5 to 4.0 ǍM 
(Bierbaum et al., 2001). The use of high performance liquid chromatography (HPLC) 
combined with an electrochemical procedure is an established method for the measurement 
of FA in vivo (Su et al., 2011). An adduct between FA and other reagents can be selectively 
separated by HPLC, and then quantified by an electrochemical approach. Using this 
method, the FA concentration of rabbit urine was found to be about 18 nM and that of 
mouse liver, kidney and brain tissues to be 63, 51 and 11 nmol/g tissue, respectively (Yu et 
al., 2003a). Another method to determine FA in blood samples by HPLC utilizes a 
fluorescence assay. Derivatization of human plasma with ampicillin leads to a fluorescent 
adduct which can be measured with a fluorescence spectrophotometer. The FA level in 
human blood as determined by Fluo-HPLC is 0.04 mM (Luo et al., 2001). Thin-layer 
chromatography can also be used to estimate the level of FA (Kalasz, 2003). In addition, the 
FA level in solid tissues such as teeth can be measured by HPLC-OPLC-MS. Results show an 
increase in FA level in carietic teeth in comparison to healthy teeth (Rozylo et al., 2000).  
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1.3.3 Degradation of endogenous formaldehyde 
The degradation of endogenous FA mainly occurs via enzymatic catalysis. Aldehyde 
dehydrogenase I, and III (ADH I, ADH III), and alcohol dehydrogenase II (ALDH II) are 
three important enzymes involved in these reactions (Iborra et al., 1992; Zhiqian Tong, 
2008). There are five classes (I-V) of alcohol dehydrogenase located in human tissues. 
Transcripts of class II (ALDH II) are abundant in the liver, but low in the stomach, pancreas 
and small intestine (Estonius et al., 1996). It has been reported that ADH III is also present in 
the human brain, being distributed mainly in the dendrites and cytoplasm of cerebellar 
Purkinje cells. The location of ADH III in the brain contributes to defending the brain 
against degeneration (Mori et al., 2000; Olson et al., 2003). In addition, S-formylglutathione 
hydrolase, glyoxalase II and catalase also function in the degradation of FA (Zhiqian Tong, 
2008). 
2. In vitro investigations 
2.1 Low concentrations of formaldehyde promote Tau aggregation 
Neuronal Tau, an important microtubule-associated protein, functions in facilitating the 
assembly of microtubules and maintaining their stability (Weingarten et al., 1975; Drechsel 
et al., 1992). Aberrant modifications of Tau protein, such as hyperphosphorylation which 
induces misfolding and aggregation, lead to microtubule system damage and subsequent 
disturbance of axonal transport and neuronal morphogenesis (Cuenda et al., 2005; Terwel et 
al., 2008). Hyperphosphorylated Tau is the major component of paired helical filaments 
(PHFs) in neurofibrillary tangles (NFTs), an important characteristic of tauopathies which 
include neurodegenerative conditions such as Alzheimer’s disease (Goedert et al., 1996; 
Hardy, 2006).  
The focus of research in our group is on the relationship between FA-meditated 
impairments and age-related dementia. Our results showed that native Tau exhibited 
globules with a diameter of 9±2 nm, while FA-treated Tau had a significantly increased 
diameter of 18±3 nm in the presence of 18.0 mM FA. The increased diameter of Tau globules 
was dependent on FA concentration. The rapid onset of aggregation (within 10 min) was 
followed by a marked increase in particle size. These results were confirmed by SDS-PAGE, 
where an increase in the polymer bands and a decrease in the monomer bands was seen 
with increasing FA concentration or time. In addition, light-scattering data (at 480 nm) 
showed that the intensity of FA-treated Tau was considerably enhanced compared with the 
control, further confirming that FA induced the aggregation of Tau (Nie et al., 2005). Thus, 
we proposed a putative mechanism of FA-induced Tau aggregation. A formaldehyde 
molecule first interacts with a Tau monomer. As additional FA molecules interact with other 
Tau monomers, the FA molecules polymerise, finally resulting in the cross-linking of the 
Tau molecules (Nie et al., 2007). 
The wormlike conformation of Tau at room temperature, as determined by circular 
dichroism (CD), is reported to have a minimal content of secondary structures (Schweers et 
al., 1994). It was observed that the probability of the collision of KI with Tyr residues became 
smaller after the aggregation of Tau, and suggesting that Tyr residues may shift to the 
interior of the Tau molecule during aggregation, leading to the lower availability of Tyr 
residues for KI. The fluorescence of 8-Anilino-1-naphthalene-sulfonic acid (ANS), a 
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fluorescent probe which binds to the hydrophobic regions of proteins, was enhanced as Tau 
was treated with FA, demonstrating the formation of a hydrophobic core during Tau 
aggregation. Protease rapidly cleaved native Tau to produce fragments with an apparent 
molecular mass of 36-37 kDa. However, no digested fragments were observed after Tau was 
incubated with FA, suggesting that the cleavage sites recognized by the protease were 
buried in the aggregates of Tau (Nie et al., 2005). In conclusion, these reports indicate that 
FA is able to induce neuronal Tau to misfold, resulting in aggregation and conformational 
changes. 
2.2 Tau aggregates induced by formaldehyde are molten globules 
Though protein misfolding is believed to induce cellular metabolic dysfunction and even 
cell death, the mechanism of this phenomenon remains unclear. A number of pathological 
mechanisms have been proposed and can be divided into two categories: one which 
suggests that the products of protein misfolding initiate the “death pathway” 
(Lipton&Nakamura, 2009; Gu et al., 2010), and the other which proposes that "aspecific 
amyloid ion channels" composed of misfolded proteins cause damage to membrane 
permeability and result in the disturbance of ion metabolism (Lin et al., 2001; Lal et al., 2005; 
Lal et al., 2007). ThT fluorescence (ǌex = 450 nm) and Congo Red staining (measured by light 
absorbance at 400 nm - 600 nm) increased markedly, indicating that Tau aggregates had 
features of amyloid-like protein. Using atomic force microscopy, we observed that FA-
induced Tau aggregates appeared to have a “pore-like” structure with a diameter of 8.94 ± 
1.62 nm in the middle of the aggregate. In addition, when Tau was incubated without FA, it 
formed fibril-like or amorphous aggregates instead of “pore-like” aggregates. It should be 
noted that these “pore-like” aggregates were observed at a high FA concentration under the 
experimental conditions, and whether they exist in vivo need to be further investigated. This 
might provide insights into the mechanism of tauopathies which result from protein 
misfolding and aggregation (Naqvi et al., 2010).  
2.3 Formaldehyde-induced aggregation interferes with Tau’s protection of DNA 
Many studies have shown that Tau protein is located in axons and neuronal soma and has 
important functions in the microtubule system as a microtubule-associated protein (Binder 
et al., 1985). Recent findings have demonstrated that Tau is also present in the nucleus 
(Loomis et al., 1990; Johnson&Davis, 1999) and functions in the protection of DNA (Galas et 
al., 2011). Heat stress and oxidative stress induce the accumulation of nonphosphorylated 
Tau in the nuclei of neurons. These nuclear Tau accumulations display an enhanced 
capacity for interacting with DNA and protect DNA from damage by stress (Galas et al., 
2011). Other studies have reported that nuclear Tau binds preferentially to polynucleotides 
of 13 bp in length, while further research has indicated that Tau binds to the minor groove 
of the DNA double helix and that both its proline-rich domain (PRD) and microtubule-
binding domain (MTBD) contribute to its interaction with DNA. This binding protects DNA 
from both digestion by DNase I and damage by peroxidation (Wei et al., 2008).  
Electrophoretic mobility shift assays (EMSA) showed that native Tau retarded the mobility 
of DNA while no retardation was observed when DNA was incubated with either Tau 
aggregates induced by FA, or with BSA, indicating that Tau binding to DNA is suppressed 
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by aggregation. That is, the aggregation of Tau induced by FA inhibits its ability to bind to 
DNA and may result in the loss of Tau’s protection of DNA (Hua&He, 2002; Lu et al., 2011). 
These observations suggest a novel mechanism of cell death during the pathological 
progress of tauopathies, such as neurodegenerative conditions.  
3. In vivo investigations 
3.1 Formaldehyde-induced aggregation of Tau can be observed in vivo 
FA induced significant aggregates in cells. Tau-1 (an antibody which recognizes Tau 
protein) signals confirmed that Tau forms aggregates in the presence of FA. In addition, 
apoptosis of HEK 293 cells transfected with tau increased, while cells transfected with a 
control vector showed no increase in apoptosis (Nie et al., 2007). In another study we found 
that FA-induced Tau aggregates promoted apoptosis in both the SH-SY5Y cell line and rat 
hippocampal primary cells (Nie et al., 2006). These reports indicate that Tau aggregates 
induced by FA lead to apoptosis. 
3.2 Formaldehyde treated mice perform abnormally in spatial reference memory tests 
Test of mice by Morris water maze showed that the latency to platform of FA-treated mice 
was twice as long as controls and the length of time they spent in the target quadrant was 
nearly half that of controls, indicating that significant impairment of spatial reference 
memory function occurred when mice were treated with FA for 30 days. When resveratrol 
(0.5 mM), a natural FA scavenger, was administrated to mice along with FA, the FA-induced 
effects on learning memory were attenuated. That is, FA-administrated mice act in abnormal 
performance in spatial reference memory tests. 
3.3 Excess endogenous formaldehyde is positively correlated with memory decline 
and cognitive impairment in animals 
Since FA can pass through the blood brain barrier (Grönvall et al, 1998; Shcherbakova et al., 
1986), it is necessary to detect the level of FA in the brain in order to determine the influence 
of FA on the central nervous system (CNS). The FA level in the brain of three types of 
Alzheimer’s disease mouse model, 5 month-old senescence accelerated mice (SAMP8), 3 
month-old APP/PS1-transgenic mice, and 6-month old APP-transgenic mice, was estimated 
by Fluo-HPLC to be about 0.33, 0.46 and 0.56 mM/g, respectively. Concentrations of FA in 
the brains of these AD models were all significantly higher than their respective controls 
(Tong et al., 2011). In addition, FA levels in the brains of rats were inversely correlated to 
their behavioral performance in the Morris water maze (Tong et al., 2011). In summary, 
endogenous FA concentrations in the brains of AD animal models (SAMP8, APP/PS1 and 
APP transgenic mice) are significantly higher than their respective controls, and excess 
endogenous FA can induce memory decline and cognitive impairment in animals. 
In addition, β-amyloid deposits, the other main characteristic of AD in addition to 
neurofibrillary tangles, increase on treatment with FA in vitro (Yu et al., 2006) and excess 
endogenous FA also promotes the deposition of A (Yu et al., 2007). Elevated levels of FA 
have also been detected in patients with multiple sclerosis (Khokhlov et al., 1989).  
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4. Clinical trials 
4.1 Urine formaldehyde levels in AD patients are correlated with the degree of 
dementia 
The study on the relationship between urine FA level and the degree of dementia showed 
that the percentage of patients with mild cognitive impairment (MCI), and medium and 
severe dementia in which concentrations of urine FA increased compared with that of age-
matched healthy controls was 42% (21/50), 82.05% (32/39) and 88.46% (46/52), respectively 
(Tong et al., 2011) (Weishan Wang, 2010).  
These results indicate that cognitive impairments of patients with age-related dementia are 
probably related to endogenous FA levels, and suggest that measuring urine FA levels 
together with mini mental state examination (MMSE) may be a useful non-invasive method 
for the investigation and diagnosis of age-related dementia. 
4.2 High levels of formaldehyde are observed in the brains of AD patients 
In addition to urine samples, we also measured the FA levels in homogenates from autopsy 
hippocampus tissues of AD patients by Fluo-HPLC. We found significant increases in the 
FA concentrations in AD patients (about 0.081 mM/g; n = 4) compared with normal controls 
(about 0.047 mM/g; n = 4) (Tong et al., 2011), indicating once again that endogenous FA 
level in AD patients is correlated with the progress of dementia.  
5. Formaldehyde stress  
Though the concept of “formaldehyde stress” has been mentioned in studies on 
Methylobacterium extorquens AMI (Miller, 2009) and tuberculosis (Bottiglioni&Sturani, 1955), 
the definition of “formaldehyde stress” in neural cells was first proposed by our group. 
Abnormal accumulation of endogenous FA can cause abnormal modifications and 
misfolding of proteins, resulting in neural cell responses such as DNA damage, and even 
cell death (Figure 1). These may lead to dysfunction of related nervous system and cognitive 
impairments (He et al., 2010).  
5.1 Endogenous formaldehyde overload can induce chronic impairment and sporadic 
age-related dementia 
Studies indicate that the level of endogenous FA in humans is maintained homeostatically 
(around 0.083 mM in urine), but increases with aging. Endogenous FA levels in AD patients 
and AD mouse models are notably higher than their respective normal controls. Stress 
induced by excess endogenous FA leads to chronic impairments of the CNS and may 
contribute to age-related dementia (He et al., 2010; Hao et al., 2011). 
5.2 Putative mechanism of formaldehyde accumulation and formaldehyde stress 
As mentioned above, generation and degradation of endogenous FA mainly depends on 
enzymatic reactions. With aging, dysfunction of these enzymes may cause abnormalities in 
the formaldehyde cycle and aberrant enzymatic production of FA from endogenous and 
exogenous substrates results in the accumulation of FA, leading to stress and subsequent 
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pathogenic neurodegeneration (Morrison et al., 1996; Tyihak et al., 1998; Kamino et al., 2000; 
Yu et al., 2003b; Unzeta et al., 2005; Unzeta et al., 2007). Other factors in aging can also 
produce excess endogenous FA. Decreased levels of glutathione (GSH) induced by oxidative 
stress lead to higher levels of endogenous FA (Tyihak et al., 1998; Ling et al., 2006).  
-amyloid peptide, a biomarker of Alzheimer’s disease, is believed to enhance ROS 
production and cause a decline in the activity of ALDH2, leading to the production of  
excess FA (Ohta&Ohsawa, 2006). APOE ε4, considered to be a risk factor of AD, can act  
synergistically with the deficiency of ALDH 2 to result in accumulation of FA (Ohta et al., 2008). 
In addition, lipid peroxidation (LPO) (Lemeshko&Nikitchenko Iu, 1982b, a; Dahl&Hadley, 
1983; Fokin et al., 1989; Halliwell&Chirico, 1993), abuse of drugs (for example, nicotine and 
cocaine) (Dahl&Hadley, 1983), and air pollutants (for example, endrin) (Bagchi et al., 1992) 
can also lead to the accumulation of FA. Polymorphisms in aldehyde dehydrogenase may be 
correlated with the metabolism and accumulation of FA (Thomasson et al., 1991; Wang et 
al., 2002; Li Hai-han 2006; Yang et al., 2008). Adh3 mutant mice are more vulnerable to FA, 
indicating that dysfunction of this gene is related to abnormal metabolism of FA and causes 
severe toxicity (Duester et al., 1999). 
metabolic response and abnormal 
modifications of proteins
protein misfolding and aggregation
cell dysfunction and death
impairments of cognition and other 
functions 
formaldehyde
 
Fig. 1. A putative scheme for formaldehyde stress. Formaldehyde stress is defined as a 
cellular response which occurs when there is an overload of formaldehyde. Under 
formaldehyde stress, abnormal modifications of proteins, such as hydroxymethylation and 
hyperphosphorylation, is present, leading to protein misfolding and aggregation and even 
to cell death. 
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6. Perspective 
Since FA level is related to cognitive impairments, eliminating excess endogenous FA may 
become a novel therapy for age-related dementia. Trans-resveratrol (trans-3,5,4'-
trihydroxystilbene, Res), a phytoalexin, is a natural ingredient in grapes and various 
medicinal plants. Res, as a scavenger of FA, can eliminate excess FA and may prevent cells 
from formaldehyde stress (Tyihak et al., 1998; Marcsek et al., 2007; Marambaud et al., 2008; 
Gibson et al., 2009; Sun et al., 2010). Antioxidant drugs, such as vitamin E and C, can inhibit 
lipid peroxidation and the resultant generation of FA (Arlt S, 2001; Yu et al., 2007; Jin-xia., 
2009). In addition, iron chelators can enhance the ability of cells to resist the cytotoxicity of 
FA (O'Brien et al., 2001). 
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Fig. 2. Formaldehyde stress and the metabolism of endogenous formaldehyde. Endogenous 
formaldehyde is generated by a variety of enzymes via deamination, demethylation and 
other reactions. Aldehyde (alcohol) dehydrogenases are the main enzymes involved in the 
degradation of formaldehyde. Endogenous formaldehyde exists in all tissues such as blood, 
urine, saliva and brain. Aberrant metabolism causes an increase in endogenous 
formaldehyde and induces formaldehyde stress, resulting in the dysfunction of organs, 
especially cognitive impairments. 
In summary, excess endogenous FA leads to “formaldehyde stress”, which causes aberrant 
modification of protein and subsequent protein misfolding and aggregation. The aggregated 
protein loses its normal physiological function and initiates cell death, organ dysfunction, 
cognitive impairments and even age-related dementia. Elimination of excess endogenous 
FA may provide an approach to the therapy of dementia (Figure 2).  
Though the relationship between endogenous FA and neurodegeneration has recently 
received considerable attention, the molecular events involved in FA-induced dementia are 
still unclear. Since the pathological factors in neurodegenerative diseases including 
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Alzheimer’s disease are complicated and synergistic, further studies should be carried out to 
reveal the mechanism by which FA contributes to the induction of age-related dementia. 
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